MiMedx Group, Inc. (NASDAQ: MDXG), , today announced that it has received notification from The Nasdaq Stock Market LLC (“Nasdaq”) indicating that, as a result of the interim progress report submitted by the Company on October 31, 2018, the Nasdaq Hearings Panel (the “Panel”) has reconsidered the Company’s request for continued listing of the Company’s common stock on The Nasdaq Capital Market
November 7, 2018
· 5 min read